CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ 29,250	$ (19,732)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	8,025	6,742
Amortization of deferred financing fees	295	280
Amortization of debt fair value adjustment	(60)	0
Amortization of restricted stock and restricted stock units	2,941	1,821
Equity in loss of unconsolidated joint ventures	4,208	6,024
Equity in earnings on sale of real estate of unconsolidated ventures	(34,982)	0
Impairment charge	520	3,642
Gain on sale of real estate	(7,693)	0
Gain on sale of partnership interest	(2,632)	0
Loss on extinguishment of debt	1,575	0
Increases and decreases from changes in other assets and liabilities:
Decrease (increase) in other assets	2,203	(108)
Decrease in accounts payable and accrued liabilities	(4,179)	(424)
Net cash used in operating activities	(529)	(1,755)
Cash flows from investing activities:
Collections from real estate loans	0	150
Proceeds from the sale of mortgage loan	0	4,000
Improvements to real estate owned	(1,308)	(887)
Purchase and consolidation of joint venture properties	(111,956)	0
Proceeds from the sale of real estate owned	24,632	0
Proceeds from the sale of joint venture interests	10,540	0
Distributions from unconsolidated joint ventures	62,025	15,273
Contributions to unconsolidated joint ventures	(6,031)	(13,700)
Net cash provided by investing activities	(22,098)	4,836
Cash flows from financing activities:
Proceeds from mortgages payable	89,680	0
Mortgage payoffs	(47,605)	0
Mortgage principal payments	(2,688)	(3,041)
Proceeds from credit facility	0	5,000
Repayment of credit facility	0	(5,000)
Increase in deferred financing costs	(319)	0
Dividends paid	(15,769)	(15,116)
Distributions to non-controlling interests	(60)	(118)
Proceeds from the sale of common stock	9,624	12,077
Repurchase of shares of common stock	0	(616)
Net cash used in financing activities	32,863	(6,814)
Net increase (decrease) in cash, cash equivalents and restricted cash:	10,236	(3,733)
Cash, cash equivalents and restricted cash at beginning of year	28,685	32,418
Cash, cash equivalents and restricted cash at end of year	38,921	28,685
Supplemental disclosures of cash flow information:
Cash paid during the year for interest expense	6,523	6,886
Cash paid during the year for income and excise taxes	173	291
Consolidation on buyout of partnership interest:
Increase in real estate assets	160,583
Increase in other assets	5,671
Increase in mortgage payable	(29,067)
Increase in deferred loan costs	748
Increase in accounts payable and accrued liabilities	(2,621)
Decrease in investment in unconsolidated joint ventures	(23,358)
Purchase and consolidation of investment in joint venture	$ 111,956